UB Therapeutics
UB Therapeutics40About
UB Therapeutics is a biotechnology company focused on developing a novel therapy for the treatment of multiple myeloma. Multiple Myeloma (MM) is the second most common cancer that affects blood cells, with a 5-year survival rate of approximately 50%.
Frequently asked
What does UB Therapeutics do?
UB Therapeutics is a biotechnology company focused on developing a novel therapy for the treatment of multiple myeloma. Multiple Myeloma (MM) is the second most common cancer that affects blood cells, with a 5-year survival rate of approximately 50%.
Where is UB Therapeutics headquartered?
UB Therapeutics is headquartered in Cambridge, United States.
When was UB Therapeutics founded?
UB Therapeutics was founded in 2017.
What industry does UB Therapeutics operate in?
UB Therapeutics operates in Life Sciences, Biotech, Oncology, Therapeutics, Drug Discovery, Clinical Trials.
What is UB Therapeutics's current status?
UB Therapeutics's current operating status is: Inactive.
Comments
No comments yet. Be the first to share your take.